The Stem Cell Podcast

Ep. 58: “Heart Disease Modeling” Featuring Dr. Lior Gepstein

Nov 24, 2015
Dr. Lior Gepstein, a clinician-scientist at Technion, dives into the fascinating realm of stem cell research focused on heart disease. He explains how human-induced pluripotent stem cells can be transformed into cardiomyocytes, crucial for understanding arrhythmias like long QT syndrome. Gepstein highlights the innovative use of genetically encoded fluorescent reporters to monitor heart cell function and the potential for personalized drug screening. His insights into regenerative therapy and biological pacemakers showcase a promising future for treating cardiac conditions.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Human Heart Cells Were Hard To Study

  • Human adult cardiomyocytes were previously impractical to study long-term in vitro.
  • Pluripotent stem cells enable generation of human heart cells for extended study and testing.
INSIGHT

Three Clear Uses For Stem-Derived Heart Cells

  • IPS and ESC-derived cardiomyocytes unlock three major applications: regeneration, drug screening, and genetic-disease modeling.
  • Patient-derived iPSCs let researchers reproduce a patient's cardiac phenotype in a dish.
ADVICE

Screen Drugs On Human Heart Cells Early

  • Screen drug effects on human cardiomyocytes early to avoid late-stage withdrawals and fatalities.
  • Use human-cell assays to detect rare cardiotoxic events before clinical trials.
Get the Snipd Podcast app to discover more snips from this episode
Get the app